Skip to main content

Novo - Young Investigator Award

Deadline - 24th of August, 2021
Amount - 25 mio DKK for 7 years

Phone: +45 7242 2587
Email: ect@novo.dk
Webpage: NNF Young Investigator Award

PURPOSE
NNF Young Investigator Awards are for outstanding younger scientists to come to Denmark to expand their groundbreaking research programs. These awards provide funding for independent early- to mid-career researchers who are ready to conduct larger and more ambitious studies. The NNF is seeking to support exceptional scientists working within any area of biomedical and/or biotechnological sciences.
 
ELIGIBILITY
An applicant must be a principal investigator with an independent research group that s/he has directed for less than 7 years in total.
An applicant may have any nationality and must be employed as a scientist outside of Denmark. An applicant may not have an employed position in Denmark during the application process.
The host institution can be anywhere in Denmark and must be a university, university hospital, public research institution or other non-profit organization.
If you have lead an independent research program for 7 or more years in total, please visit the Laureate Research Grant page.
 
FUNDING
Up to 4 NNF Young Investigator Awards will be granted in 2021.
Awards up to DKK 25 million (EUR ~3.4 M, USD ~3.7 M) for a period of 7 years. Up to DKK 7 million may be utilized for establishment of the laboratory during the first year, with following years funded at up to DKK 3 million per year.
 
APPLICATION PROCESS
The application process consists of two stages. Stage I applications must be completed and submitted using the NNF’s application system following the instructions in the “Information and guidelines for applicants” pdf, found on this website when the system opens. Additional essential information regarding eligibility, funding and the application process is found in this pdf.
Up to 6 applicants will be invited to stage II. The major elements of the stage II application will be a comprehensive research program proposal and a letter of commitment from the host institution in Denmark. Stage II applicants will be invited to the Novo Nordisk Foundation for an interview with the NNF review committee.
Evaluation of applications and selection of grant awardees will be based on scientific excellence, originality and potential impact.

NNF